Followers | 14 |
Posts | 1484 |
Boards Moderated | 1 |
Alias Born | 02/12/2017 |
Tuesday, April 17, 2018 9:25:34 AM
This is the FDA Briefing Document for Thursday's Advisory Committee meeting:
https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf
“Conclusions
Clinically meaningful and statistically significant reductions in seizure frequency were demonstrated in three adequate and well-controlled trials in LGS and DS. The results from these three studies provide substantial evidence of the effectiveness of CBD for the treatment of seizures associated with LGS and DS. In general, the risks associated with CBD treatment appear acceptable, particularly given the findings of clinical efficacy in LGS and DS, which are serious, debilitating, and life-threatening disorders. Although the risk of liver injury has the potential to be serious, the observed risk can be appropriately managed with inclusion of relevant language in labeling, education of prescribers regarding the risk of transaminase elevation and need for monitoring of liver enzyme levels, and further characterization of the risk in the post-market setting. Although the review is still ongoing, the risk-benefit profile established by the data in the application appears to support approval of cannabidiol for the treatment of seizures associated with LGS and DS.”
Handcrafted cannabis investments
Recent VPRB News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 11:00:24 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:10:02 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:14:37 PM
- VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • InvestorsHub NewsWire • 05/17/2024 12:04:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/16/2024 08:06:07 PM
- VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • InvestorsHub NewsWire • 04/19/2024 03:24:43 PM
- Turning Point Brands Canada Named Exclusive Master Distributor for VPR Brands' HoneyStick in Canada • InvestorsHub NewsWire • 01/05/2024 12:13:41 PM
- VPR Brands LP Announces Strong Financial Results for Q3 2023 • InvestorsHub NewsWire • 11/15/2023 12:22:19 PM
- VPRB is Proud to Announce Its Uplisting to the OTCQB Market • InvestorsHub NewsWire • 10/10/2023 11:08:14 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM